£290K
The financing draws backing from the founding team and a US family office.
VT
Virokine Therapeutics
Developing viral immunotherapeutics for oncology, infections, and autoimmune diseases.
London, UK—Founded 2020
£290KTotal raised
Virokine Therapeutics is a biotechnology developer focusing on immunotherapeutics derived from viruses to address cancer, infections, and autoimmune conditions.
Filed accounts
Cash at bank
Members only
Net assets
Members only
Shareholders' funds
Members only
Cash, assets and headcount from Virokine Therapeutics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
MM
Michael Martin